Company profile

Humacyte, Inc. insider acquisitions

Company CIK 0001818382 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
HUMA · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Kuznik Paul BrianKuznik Paul BrianCOWARD D SCOTTCOWARD D SCOTTSander Dale A.Sander Dale A.Parikh Shamik JParikh Shamik JDougan Brady WDougan Brady WNiklason Laura ENiklason Laura EKuznik Paul Brian · October 6, 2026 · Stock award · Stock Options (right to buy)COWARD D SCOTT · October 6, 2026 · Stock award · Stock Options (right to buy)Sander Dale A. · November 16, 2025 · Stock award · Common StockParikh Shamik J · November 16, 2025 · Stock award · Common StockDougan Brady W · November 16, 2025 · Stock award · Stock Options (right to buy)Niklason Laura E · November 16, 2025 · Stock award · Stock Options (right to buy)Nov 16, 2025Oct 6, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

6 dated transactions · 6 of 6 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 6, 2026Humacyte, Inc.Stock Options (right to buy)Kuznik Paul BrianStock award
Oct 6, 2026Humacyte, Inc.Stock Options (right to buy)COWARD D SCOTTStock award
Nov 16, 2025Humacyte, Inc.Common StockSander Dale A.Stock award
Nov 16, 2025Humacyte, Inc.Common StockParikh Shamik JStock award
Nov 16, 2025Humacyte, Inc.Stock Options (right to buy)Dougan Brady WStock award
Nov 16, 2025Humacyte, Inc.Stock Options (right to buy)Niklason Laura EStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

HUMA · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Stock awardStock Options (right to buy)Derivative security · Code A125,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Options (right to buy)Derivative security · Code A125,0000Value: 0Currency not specifiedView ↗
Trade:
Sander Dale A.CFO and Chief Corp. Deve. Off.
Stock awardCommon StockNon-derivative security · Code A311,1000Value: 0Currency not specifiedView ↗
Trade:
Parikh Shamik JChief Medical Officer
Stock awardCommon StockNon-derivative security · Code A311,1000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Options (right to buy)Derivative security · Code A311,1000Value: 0Currency not specifiedView ↗
Trade:
Niklason Laura EPresident, CEO and Director · Director
Stock awardStock Options (right to buy)Derivative security · Code A311,1000Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →